快速连接 发送消息
Shanghai, June 26, 2025 —Dr. Reddy’s Laboratories’ Active Pharmaceutical Ingredients (API) business made a dynamic appearance at CPHI China 2025, held at the Shanghai New International Expo Center from June 24–26.
Held at the Shanghai New International Expo Center, the event gave us the opportunity to connect with formulation partners, regulatory experts, and innovators from around the world. We proudly presented our portfolio of 250+ APIs, spanning oncology, cardiology, pain management, and more each backed by rigorous science and global regulatory compliance. Our team, led by Deepak Sapra and Nirav Shah, engaged in meaningful conversations around early market entry strategies, complex API development, and sustainable manufacturing practices. We were especially excited to share our progress on ESG goals and our recognition in global sustainability indices.
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。
+91 4049002253